Eli Lilly in advanced talks to acquire Kelonia Therapeutics: WSJ
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters U.S. drugmaker Eli Lilly is in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reported on Sunday. A deal could be reached as soon…